Time to Colonoscopy and Risk of Colorectal Cancer in Patients With Positive Results From Fecal Immunochemical Tests

Clinical Gastroenterology and Hepatology

Volumn 17, Issue 7, 2019, Pages 1332-1340.e3

  Lee, Yi Chia ^a,b   Fann, Jean Ching Yuan ^c   Chiang, Tsung Hsien ^a,d   Chuang, Shu Lin ^b   Chen, Sam Li Sheng ^e   Chiu, Han Mo ^a,b   Yen, Amy Ming Fang ^e   Chiu, Sherry Yueh Hsia ^f,g   Hsu, Chen Yang ^b   Hsu, Wen Feng ^a,b   Wu, Ming Shiang ^a   Chen, Hsiu Hsi ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c KAINAN UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^f CHANG GUNG UNIVERSITY   (Taiwan)

^g CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Colon Cancer; Endoscopy; Population; Prevention

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RISK; CANCER STAGING; CLINICAL EVALUATION; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL CANCER; DISEASE ASSOCIATION; DISEASE COURSE; FECES ANALYSIS; FEMALE; FOLLOW UP; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; RISK FACTOR; CHEMISTRY; CLINICAL TRIAL; COLORECTAL TUMOR; FECES; IMMUNOHISTOCHEMISTRY; INCIDENCE; MASS SCREENING; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; RETROSPECTIVE STUDY; TAIWAN; TIME FACTOR;

TUMOR MARKER;

AGED; BIOMARKERS, TUMOR; COLONOSCOPY; COLORECTAL NEOPLASMS; FECES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; RETROSPECTIVE STUDIES; TAIWAN; TIME FACTORS;

EID: 85065764779     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2018.10.041     Document Type: Article

References (20)

1. Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2017. CA Cancer J Clin 67 (2017), 7–30.
2. US Preventive Services Task Force Bibbins-Domingo, K., Grossman, D.C., Curry, S.J., et al. Screening for colorectal cancer: US Preventive Services Task Force Recommendation Statement. JAMA 315 (2016), 2564–2575.
3. Lee, J.K., Liles, E.G., Bent, S., et al. Accuracy of fecal immunochemical tests for colorectal cancer. Ann Intern Med 160 (2014), 171–181.
4. Katsoula, A., Paschos, P., Haidich, A.B., et al. Diagnostic accuracy of fecal immunochemical test in patients at increased risk for colorectal cancer: a meta-analysis. JAMA Intern Med 177 (2017), 1110–1118.
5. Chen, C.D., Yen, M.F., Wang, W.M., et al. A case-cohort study for the disease natural history of adenoma-carcinoma and de novo carcinoma and surveillance of colon and rectum after polypectomy: implication for efficacy of colonoscopy. Br J Cancer 88 (2003), 1866–1873.
6. Corley, D.A., Jensen, C.D., Quinn, V.P., et al. Association between time to colonoscopy after a positive fecal test result and risk of colorectal cancer and cancer stage at diagnosis. JAMA 317 (2017), 1631–1641.
7. Chiu, H.M., Chen, S.L., Yen, A.M., et al. Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program. Cancer 121 (2015), 3221–3229.
8. Chiang, T.H., Chuang, S.L., Chen, S.L., et al. Difference in performance of fecal immunochemical tests with the same hemoglobin cutoff concentration in a nationwide colorectal cancer screening program. Gastroenterology 147 (2014), 1317–1326.
9. Lee, Y.C., Li-Sheng Chen, S., Ming-Fang Yen, A., et al. Association between colorectal cancer mortality and gradient fecal hemoglobin concentration in colonoscopy noncompliers. J Natl Cancer Inst, 109, 2017, dwj269.
10. Chiu, S.Y., Chuang, S.L., Chen, S.L., et al. Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program. Gut 66 (2017), 293–300.
11. Chou, C.K., Chen, S.L., Yen, A.M., et al. Outreach and inreach organized service screening programs for colorectal cancer. PLoS One, 11, 2016, e0155276.
12. Lee, Y.C., Hsu, C.Y., Chen, S.L., et al. Effects of screening and universal healthcare on long-term colorectal cancer mortality. Int J Epidemiol, 2018 Sep 3, 10.1093/ije/dyy182 [Epub ahead of print].
13. Wen, C.P., Tsai, S.P., Chung, W.S., A 10-year experience with universal health insurance in Taiwan: measuring changes in health and health disparity. Ann Intern Med 148 (2008), 258–267.
14. Bosman, F.T., Carneiro, F., Hruban, R.H., et al. (eds.) WHO classification of tumours of the digestive system, 2010, IARC, Lyon.
15. Chiang, C.J., Chen, Y.C., Chen, C.J., et al. Taiwan Cancer Registry Task Force. Cancer trends in Taiwan. Jpn J Clin Oncol 40 (2010), 897–904.
16. AJCC Edge, S.B., Byrd, D.R., Carducci, M.A., et al. (eds.) American Joint Committee on Cancer (AJCC) Cancer Staging Manual, 7th ed., 2009, Springer, New York.
17. Meester, R.G., Zauber, A.G., Doubeni, C.A., et al. Consequences of increasing time to colonoscopy examination after positive result from fecal colorectal cancer screening test. Clin Gastroenterol Hepatol 14 (2016), 1445–1451.
18. Cheng, S.Y., Li, M.C., Chia, S.L., et al. Factors affecting compliance with confirmatory colonoscopy after a positive fecal immunochemical test in a national colorectal screening program. Cancer 124 (2018), 907–915.
19. Paterson, W.G., Depew, W.T., Pare, P., et al. Canadian Association of Gastroenterology Wait Time Consensus Group. Canadian consensus on medically acceptable wait times for digestive health care. Can J Gastroenterol 20 (2006), 411–423.
20. Moss, S., Ancelle-Park, R., Brenner, H., International Agency for Research on Cancer. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition –Evaluation and interpretation of screening outcomes. Endoscopy 44:Suppl 3 (2012), SE49–SE64.